These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24265950)

  • 1. Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center.
    Kwon JC; Kim SH; Choi JK; Cho SY; Park YJ; Park SH; Choi SM; Lee DG; Choi JH; Yoo JH
    Infect Chemother; 2013 Mar; 45(1):51-61. PubMed ID: 24265950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
    Choi H; Ahn H; Lee R; Cho SY; Lee DG
    Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infections in neutropenic patients with haematological malignancies.
    Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
    Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms.
    Ahmed SH; Daef EA; Badary MS; Mahmoud MA; Abd-Elsayed AA
    BMC Res Notes; 2009 May; 2():76. PubMed ID: 19419535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study.
    Zhu Q; Yue Y; Zhu L; Cui J; Zhu M; Chen L; Yang Z; Liang Z
    Antimicrob Resist Infect Control; 2018; 7():107. PubMed ID: 30202520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology-Oncology Unit: A 10-Year Study.
    Mattei D; Baretta V; Mazzariol A; Maccacaro L; Balter R; Zaccaron A; Bonetti E; Chinello M; Vitale V; Caddeo G; Esposto MP; Pezzella V; Gibellini D; Tridello G; Cesaro S
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
    Cordero L; Rau R; Taylor D; Ayers LW
    Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit.
    Bizzarro MJ; Dembry LM; Baltimore RS; Gallagher PG
    Infect Control Hosp Epidemiol; 2008 Oct; 29(10):914-20. PubMed ID: 18808341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology, drug sensitivity profiles and clinical outcome of bloodstream infections: A retrospective study of 784 pediatric patients with hematological and neoplastic diseases.
    Chen S; Liu S; Yuan X; Mai H; Lin J; Wen F
    Pediatr Hematol Oncol; 2019 Nov; 36(8):482-493. PubMed ID: 31718370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012-2019.
    Li M; Du M; Li H; Liu D; Liu Y
    Infect Med (Beijing); 2022 Mar; 1(1):23-30. PubMed ID: 38074981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010-2021).
    Alonso-Menchén D; Sánchez-Carrillo C; Alcalá L; Soriano-Martín A; Cercenado E; Burillo A; Serrano-Lobo J; Pérez-Latorre L; Muñoz P; Bouza E
    Infect Dis (Lond); 2024 Jun; 56(6):441-450. PubMed ID: 38407125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy.
    Chen S; Lin K; Li Q; Luo X; Xiao M; Chen M; Zhu H; Chen Y; Wu X; Zeng Y; Zhang Y; Ally IH; Xu J; Ren J; Chen Z; Hu J; Yang T
    J Cancer; 2021; 12(18):5494-5505. PubMed ID: 34405012
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
    Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.